The Impact of b/tsDMARD Dose Reduction on Chronic Hepatitis B in Rheumatoid Arthritis Patients: A Two-Center Long-Term Safety Analysis.
Der-Yuan ChenHsin-Hua ChenShih-Hsin ChangYi Ming ChenPo-Hao HuangChia-Wei HsiehJoung-Liang LanKuo-Tung TangPublished in: Journal of clinical medicine (2022)
The HBV viral load decreased after the tapering of b/tsDMARDs in RA patients with detectable HBV DNA. Dose reduction in b/tsDMARDs might be beneficial.